Pyott David E I - Net Worth and Insider Trading
Pyott David E I Net Worth
The estimated net worth of Pyott David E I is at least $112 Million dollars as of 2024-04-26. Pyott David E I is the Chairman of the Board and CEO of Allergan PLC and owns about 399,168 shares of Allergan PLC (AGN) stock worth over $77 Million. Pyott David E I is the Director of Edwards Lifesciences Corp and owns about 290,574 shares of Edwards Lifesciences Corp (EW) stock worth over $25 Million. Pyott David E I is also the Director of Alnylam Pharmaceuticals Inc and owns about 27,900 shares of Alnylam Pharmaceuticals Inc (ALNY) stock worth over $4 Million. Besides these, Pyott David E I also holds Avery Dennison Corp (AVY) , Biomarin Pharmaceutical Inc (BMRN) . Details can be seen in Pyott David E I's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Pyott David E I has not made any transactions after 2020-08-31 and currently still holds the listed stock(s).
Transaction Summary of Pyott David E I
Pyott David E I Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pyott David E I owns 5 companies in total, including Biomarin Pharmaceutical Inc (BMRN) , Alnylam Pharmaceuticals Inc (ALNY) , and Avery Dennison Corp (AVY) among others .
Click here to see the complete history of Pyott David E I’s form 4 insider trades.
Insider Ownership Summary of Pyott David E I
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2020-08-31 | director |
| ALNY | Alnylam Pharmaceuticals Inc | 2016-10-13 | director |
| AVY | Avery Dennison Corp | 2020-02-03 | director |
| EW | Edwards Lifesciences Corp | 2013-05-01 | director |
| PLRX | Pliant Therapeutics Inc | 2021-01-12 | director |
Pyott David E I Latest Holdings Summary
Pyott David E I currently owns a total of 5 stocks. Among these stocks, Pyott David E I owns 399,168 shares of Allergan PLC (AGN) as of February 12, 2014, with a value of $77 Million and a weighting of 68.53%. Pyott David E I owns 290,574 shares of Edwards Lifesciences Corp (EW) as of May 1, 2013, with a value of $25 Million and a weighting of 22.34%. Pyott David E I also owns 27,900 shares of Alnylam Pharmaceuticals Inc (ALNY) as of October 13, 2016, with a value of $4 Million and a weighting of 3.56%. The other 2 stocks Avery Dennison Corp (AVY) , Biomarin Pharmaceutical Inc (BMRN) have a combined weighting of 5.58% among all his current holdings.
Latest Holdings of Pyott David E I
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGN | Allergan PLC | 2014-02-12 | 399,168 | 193.02 | 77,047,407 |
| EW | Edwards Lifesciences Corp | 2013-05-01 | 290,574 | 86.43 | 25,114,311 |
| ALNY | Alnylam Pharmaceuticals Inc | 2016-10-13 | 27,900 | 143.31 | 3,998,349 |
| AVY | Avery Dennison Corp | 2020-02-03 | 17,270 | 219.03 | 3,782,648 |
| BMRN | Biomarin Pharmaceutical Inc | 2020-08-31 | 30,740 | 80.91 | 2,487,173 |
Holding Weightings of Pyott David E I
Pyott David E I Form 4 Trading Tracker
According to the SEC Form 4 filings, Pyott David E I has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 252,000 shares on February 12, 2014, which brought Pyott David E I around $31 Million.
According to the SEC Form 4 filings, Pyott David E I has made a total of 0 transactions in Edwards Lifesciences Corp (EW) over the past 5 years. The most-recent trade in Edwards Lifesciences Corp is the acquisition of 18,000 shares on May 1, 2013, which cost Pyott David E I around $188,850.
According to the SEC Form 4 filings, Pyott David E I has made a total of 0 transactions in Alnylam Pharmaceuticals Inc (ALNY) over the past 5 years. The most-recent trade in Alnylam Pharmaceuticals Inc is the acquisition of 27,900 shares on October 13, 2016, which cost Pyott David E I around $1 Million.
More details on Pyott David E I's insider transactions can be found in the Insider Trading History of Pyott David E I table.Insider Trading History of Pyott David E I
- 1
Pyott David E I Trading Performance
GuruFocus tracks the stock performance after each of Pyott David E I's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pyott David E I is 12.48%. GuruFocus also compares Pyott David E I's trading performance to market benchmark return within the same time period. The performance of stocks bought by Pyott David E I within 3 months outperforms 3 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pyott David E I's insider trading performs compared to the benchmark.
Performance of Pyott David E I
Average Return
80.95%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.06 | 12.48 | 14.75 | 80.95 | 36.16 | 30.95 |
| Relative Return to S&P 500(%) | 7.57 | 8.7 | 6.93 | 59.42 | 23.15 | 20.63 |
Pyott David E I Ownership Network
Ownership Network List of Pyott David E I
Ownership Network Relation of Pyott David E I
Pyott David E I Owned Company Details
What does Biomarin Pharmaceutical Inc do?
Who are the key executives at Biomarin Pharmaceutical Inc?
Pyott David E I is the director of Biomarin Pharmaceutical Inc. Other key executives at Biomarin Pharmaceutical Inc include director & Chief Executive Officer Jean Jacques Bienaime , GVP & Chief Accounting Officer Erin Burkhart , and VP & General Counsel George Eric Davis .
Biomarin Pharmaceutical Inc (BMRN) Insider Trades Summary
Over the past 18 months, Pyott David E I made no insider transaction in Biomarin Pharmaceutical Inc (BMRN). Other recent insider transactions involving Biomarin Pharmaceutical Inc (BMRN) include a net sale of 291,000 shares made by Jean Jacques Bienaime , a net sale of 61,000 shares made by Jeffrey Robert Ajer , and a net sale of 17,380 shares made by Brian Mueller .
In summary, during the past 3 months, insiders sold 139,229 shares of Biomarin Pharmaceutical Inc (BMRN) in total and bought 0 shares, with a net sale of 139,229 shares. During the past 18 months, 482,233 shares of Biomarin Pharmaceutical Inc (BMRN) were sold and 3,625 shares were bought by its insiders, resulting in a net sale of 478,608 shares.
Biomarin Pharmaceutical Inc (BMRN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Biomarin Pharmaceutical Inc Insider Transactions
Pyott David E I Mailing Address
Above is the net worth, insider trading, and ownership report for Pyott David E I. You might contact Pyott David E I via mailing address: C/o Allergan, 2525 Dupont Drive, Irvine Ca 92612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
